Sézary syndrome (SS) is an aggressive cutaneous T cell lymphoma with poor prognosis mainly characterized by the expansion of a tumor CD4+ T cell clone in both skin and blood. Here, CD4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.